Database

Startups

Main Industry
Biotechnology
Main Product/Service
1. Healthy Intestines to Probiotics
2. Plant extract shampoo
Founded Year
2014
Unified Business No.
54802983
Status
Active
Number of Employees
0
Total Paid-in Capital
108,931,350 (NT$)
Location of Company
Taiwan , Hsinchu City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
About the Company
ARJIL Pharmaceuticals LLC, founded in 2014, is a clinical-stage biopharmaceutical company pioneering innovative therapies. Our pipeline focuses on botanical-based medicines and promising small molecule drug candidates, aiming to improve the health and well-being of aging individuals. As of 2024, Arjil‘s funding investment has exceeded 8 million US Dollars.



more ↓

Similar Companies

EVERFRONT BIOTECH INC.

1. EF-001 (Cerebraca® Wafer)
2. EF-009 Wafer
3. HK-001
4. EF-031
5. TSCA-001
6. EF-011

Rephlmmune Biotechnology Inc.

RephImmune is pioneering a new frontier in cancer immunotherapy with its proprietary platform, Reconstitute-Immunity Antigen-Cell Engager (RACE). This cutting-edge technology is rooted in regeneration biology and is specifically designed to reprogram and

ARCE THERAPEUTICS, INC.

ARD103
ANTI-CLL1 auto-CAR-T
ARD103, our priority product, is an autologous CAR-T cell manufactured by DashCAR® technology with an ultra-fast processing time and stem cell-like phenotypes. ARD103 specifically targeted C-type lectin-like molecule-1 (CLL-1)
:::
回頁面最頂端